{
    "clinical_study": {
        "@rank": "88929", 
        "arm_group": [
            {
                "arm_group_label": "Closone", 
                "arm_group_type": "Experimental", 
                "description": "75mg/100mg per day, 8weeks, PO"
            }, 
            {
                "arm_group_label": "Plavix with Astrix", 
                "arm_group_type": "Active Comparator", 
                "description": "75mg per day, 8weeks, PO 100mg per day, 8weeks, PO"
            }
        ], 
        "brief_summary": {
            "textblock": "The Aim of this study is to prove non-inferiority of Closone to the Combination treatment of\n      Plavix with Astrix."
        }, 
        "brief_title": "Phase IV Study to Compare Efficacy and Safety of Plavix 75mg With Astrix 100mg and Closone", 
        "completion_date": {
            "#text": "August 2013", 
            "@type": "Actual"
        }, 
        "condition": "Coronary Artery Disease", 
        "condition_browse": {
            "mesh_term": [
                "Coronary Artery Disease", 
                "Myocardial Ischemia", 
                "Coronary Disease"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Subjects under a stable condition after Post-Percutaneous Coronary Artery\n             Intervention over three months\n\n          -  20~86 years old\n\n          -  Willing to adhere to protocol requirements and sign a informed consent form\n\n        Exclusion Criteria:\n\n          -  Subject who did not undergo or failed Drug-Stent Implantation\n\n          -  Subjects who took an anti-coagulant, anti-thrombotic regularlly( \u2265 2weeks in a month)\n             before the study, or plan to have continuous treatment during the study(Except\n             Aspirin alone or combination of Aspirin and Clopidogrel)\n\n          -  Subjects with a history of substance or alchol abuse\n\n          -  Subjects with a history of hypersensitivity to Clopidogrel, Aspirin or other NSAIDS\n\n          -  Subjects having Aspirin or other NSAIDs-induced Asthma or history\n\n          -  Subjects with Severe hepatopathy(AST and ALT > 5 times the upper limit of normal)\n\n          -  Subjects with Severe nephropathy(Cr > 3 times the upper limit of normal)\n\n          -  Subjects with hemorrhage like gastric ulcer, intracranial hemorrhage etc.\n\n          -  Subjects with high risk of hemorrhage like blood coagulation disorders, uncontrolled\n             severe hypertension, active bleeding, history of severe bleeding\n\n          -  subjects who are pregnant, breastfeeding\n\n          -  Subjects not using medically acceptable birth control\n\n          -  Subjects who are unsuitable to take the Investigational product due to a\n             medical/mental condition\n\n          -  Subjects inherently having Galactose malobsorption, Lactase deficiency or\n             Glucose-Galactose malobsorption"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "85 Years", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "285", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "January 7, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01765452", 
            "org_study_id": "CJ_CLO_401"
        }, 
        "intervention": [
            {
                "arm_group_label": "Closone", 
                "description": "75mg/100mg, 8weeks, PO", 
                "intervention_name": "Closone", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Plavix with Astrix", 
                "description": "75mg, 100mg a day, 8weeks, PO", 
                "intervention_name": "Plavix with Astrix", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Clopidogrel"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "May 9, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Busan", 
                        "country": "Korea, Republic of"
                    }, 
                    "name": "Inje university haeundae paik hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Busan", 
                        "country": "Korea, Republic of"
                    }, 
                    "name": "Kosin university gospel hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Busan", 
                        "country": "Korea, Republic of"
                    }, 
                    "name": "Pusan national university hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chungbuk", 
                        "country": "Korea, Republic of"
                    }, 
                    "name": "Chungbuk national university hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Gyeonggi-do", 
                        "country": "Korea, Republic of"
                    }, 
                    "name": "Dongguk University Medical Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Seoul", 
                        "country": "Korea, Republic of"
                    }, 
                    "name": "Seoul National University Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Seoul", 
                        "country": "Korea, Republic of"
                    }, 
                    "name": "SNU Boramae Medical Center"
                }
            }
        ], 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "2", 
        "official_title": "Multi-center, Randomized, Open Study for Comparison of Efficacy and Safety of Plavix With Astrix and Closone in Patients With Post-Percutaneous Coronary Artery Intervention", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Korea: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "August 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Change from baselinine in P2Y12% inhibition at week 8", 
            "safety_issue": "No", 
            "time_frame": "Baseline, week 8"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01765452"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "Change from baseline in PRU, ARU at week 8", 
            "safety_issue": "No", 
            "time_frame": "Baseline, week 8"
        }, 
        "source": "CJ HealthCare Corporation", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "CJ HealthCare Corporation", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "October 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}